Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Lymphoma, Non-Hodgkin 2Lymphoma, Mantle-Cell 2Lymphoma, Large B-Cell, Diffuse 2Lymphoma, Follicular 2Leukemia, Lymphocytic, Chronic, B-Cell 2Carcinoma, Renal Cell 2Thrombocytopenia 1Stomach Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pancreatic Neoplasms 1Multiple Myeloma 1Melanoma 1Lymphoma, Large-Cell, Immunoblastic 1Lymphoma, B-Cell, Marginal Zone 1Leukemia, Myelomonocytic, Chronic 1Leukemia, Myeloid, Chronic-Phase 1Leukemia, Myeloid, Acute 1Leukemia, Myeloid, Accelerated Phase 1Hemoglobinuria, Paroxysmal 1Fallopian Tube Neoplasms 1Congenital Abnormalities 1Carcinoma, Ovarian Epithelial 1Burkitt Lymphoma 1Blast Crisis 1Anemia, Refractory 1AIDS-related Diffuse Large Cell Lymphoma 1

Interventions

Carboplatin 29Paclitaxel 22Taxes 16Bevacizumab 15Specimen Handling 10Immunoglobulin G 10Disulfides 10Magnetic Resonance Spectroscopy 9Gemcitabine 9Biopsy 9veliparib 8olaparib 8liposomal doxorubicin 7cediranib 6Doxorubicin 6Docetaxel 6Topotecan 5Chemotherapy, Adjuvant 4Oxaliplatin 3Immunohistochemistry 3Gene Expression Profiling 3temsirolimus 2reolysin 2oregovomab 2ipatasertib 2cabozantinib 2berzosertib 2belinostat 2atezolizumab 2aflibercept 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Fallopian Tube Neoplasms × Bryostatins × Clear all
NCT00006942 2013-08-26

Bryostatin 1 and Cisplatin in Treating Patients With Advanced Recurrent or Residual Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer

National Cancer Institute (NCI)

Phase 2 Completed
32 enrolled
Gynecologic

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡